Form 4: Intuitive Surgical EVP Robert DeSantis Executes Stock Option Plan
SEC Form 4
Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, executed stock options and sold shares under a pre-arranged trading plan.
Summary
- Robert DeSantis, an executive at Intuitive Surgical, engaged in multiple transactions involving the company's common stock on April 26 and April 29, 2024.
- These transactions included the exercise of non-qualified stock options and the subsequent sale of the acquired shares.
- The sales were executed at varying prices, ranging from $368.1 to $375.39 per share.
- The exercise prices for the options ranged from $179.7 to $347.4167.
- These transactions were conducted under a pre-arranged trading plan complying with SEC Rule 10b5-1, which expires on December 9, 2024.
- Following these transactions, DeSantis directly owns 5,507 shares of Intuitive Surgical common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading strategy and do not necessarily indicate a change in the executive's confidence in the company.
Positives
- The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating transparency and pre-planning.
Future Outlook
The executive will continue to execute trades under the 10b5-1 trading plan until its expiration on December 9, 2024.
Industry Context
Executive stock transactions are a normal part of corporate governance and compensation practices in the medical device industry. These transactions can be influenced by factors such as company performance, market conditions, and individual financial planning.
Comparison to Industry Standards
- Executive compensation practices, including stock options, are common in the medical device industry.
- Companies like Stryker, Medtronic, and Johnson & Johnson also utilize stock options as part of their executive compensation packages.
- The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small volume of shares involved.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/10/2023 | Date relevant to vesting schedule of some stock options. |
| 08/10/2023 | Date relevant to vesting schedule of some stock options. |
| 04/26/2024 | Date of multiple stock option exercises and sales. |
| 04/29/2024 | Date of stock option exercises and sales. |
| 04/30/2024 | Date of Form 4 filing. |
| 12/09/2024 | Expiration date of the Rule 10b5-1 trading plan. |
| 02/28/2029 | Expiration date of some stock options. |
| 08/28/2029 | Expiration date of some stock options. |
| 05/11/2030 | Expiration date of some stock options. |
| 02/27/2030 | Expiration date of some stock options. |
| 08/09/2030 | Expiration date of some stock options. |
| 02/26/2031 | Expiration date of some stock options. |
| 08/26/2031 | Expiration date of some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.